TECH
Bio-Techne Corporation
Stock
$72.400.00 (0.00%)Close Oct 2, 2026
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1.2B | $1.2B | $1.1B | $1.1B | $931M | $739M | $714M | $643M | $563M | $499M | $452M | $358M | $311M | $315M | $290M | $269M | $264M |
| Cost of revenue | $416M | $429M | $389M | $367M | $349M | $298M | $255M | $241M | $211M | $188M | $162M | $145M | $106M | $79M | $79M | $65M | $55M | $56M |
| Gross profit | $799M | $790M | $770M | $770M | $756M | $633M | $483M | $473M | $432M | $375M | $337M | $307M | $251M | $231M | $236M | $225M | $214M | $208M |
| R&D | $95M | $99M | $97M | $92M | $87M | $71M | $65M | $62M | $55M | $54M | $45M | $41M | $31M | $29M | $28M | $26M | $25M | $24M |
| SG&A | $452M | $589M | $466M | $378M | $373M | $325M | $261M | $264M | $241M | $200M | $141M | $119M | $61M | $43M | $42M | $36M | $33M | $34M |
| Other operating expenses | — | — | — | — | — | — | — | — | — | — | — | — | $160M | — | — | — | — | — |
| Operating income | $252M | $102M | $207M | $299M | $297M | $237M | $157M | $147M | $136M | $121M | $151M | $147M | $160K | $158M | $166M | $163M | $156M | $151M |
| Non-operating income | −$11M | −$3.8M | −$21M | $40M | $4.8M | −$89M | $119M | −$35M | −$10M | −$8.6M | −$3.1M | $7.1M | $161M | $2.2M | −$4.0M | $1.9M | $118K | — |
| Pretax income | $241M | $98M | $186M | $339M | $301M | $148M | $276M | $112M | $126M | $112M | $147M | $154M | $161M | $161M | $162M | $165M | $156M | — |
| Taxes | $59M | $25M | $18M | $53M | $29M | $7.8M | $47M | $16M | −$198K | $36M | $43M | $46M | $50M | $48M | $50M | $53M | $47M | — |
| Net income | $182M | $73M | $168M | $285M | $272M | $140M | $229M | $96M | $126M | $76M | $104M | $108M | $111M | $113M | $112M | $112M | $110M | $105M |
| Diluted EPS | $1.16 | $0.46 | $1.05 | $1.76 | $1.66 | $0.87 | $1.46 | $0.62 | $0.83 | $0.51 | $0.70 | $0.72 | $0.75 | $0.76 | $0.76 | $0.76 | $0.74 | $0.70 |
| Diluted shares | 157.0M | 159.7M | 160.8M | 161.9M | 164.1M | 161.9M | 157.6M | 155.6M | 152.2M | 150.0M | 149.3M | 148.9M | 148.0M | 147.6M | 148.0M | 148.7M | 149.4M | 151.6M |
| Revenue growth | −0.4% | +5.2% | +2.0% | +2.8% | +18.7% | +26.0% | +3.5% | +11.0% | +14.2% | +12.8% | +10.3% | +26.4% | +15.2% | −1.3% | +8.5% | +7.8% | +1.9% | — |
| Gross margin | 65.8% | 64.8% | 66.4% | 67.7% | 68.4% | 68.0% | 65.4% | 66.3% | 67.2% | 66.5% | 67.5% | 67.9% | 70.3% | 74.4% | 75.0% | 77.6% | 79.6% | 78.8% |
| Operating margin | 20.7% | 8.4% | 17.8% | 26.3% | 26.8% | 25.5% | 21.3% | 20.5% | 21.2% | 21.4% | 30.2% | 32.5% | 0.0% | 51.0% | 52.8% | 56.2% | 58.1% | 57.1% |
| Net margin | 15.0% | 6.0% | 14.5% | 25.1% | 24.6% | 15.1% | 31.0% | 13.5% | 19.6% | 13.5% | 20.9% | 23.8% | 31.0% | 36.2% | 35.7% | 38.7% | 40.8% | 39.9% |